Reposted by Eduardo Marbán, MD, PhD
Suggesting a novel therapy for systemic sclerosis: doi.org/10.1172/jci....
@eduardomarban.bsky.social & team report that an orally delivered noncoding RNA (TY1) reduces inflammation and organ fibrosis in models of systemic sclerosis through inhibition of the cGAS/STING axis.
@the-asci.org